California Public Employees Retirement System Arbutus Biopharma Corp Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.5 - $3.51 $306,750 - $430,677	-122,700 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$2.76 - $4.97 $7,175 - $12,922	-2,600 Reduced 2.08%	122,700 $436,000
Q3 2020 Nov 05, 2020	BUY	$1.75 - $6.2 $219,275 - $776,860	125,300 New	125,300 $392,000

Others Institutions Holding ABUS

# of Institutions

157

Shares Held

99.6M

Call Options Held

2.31M

Put Options Held

525K

Morgan Stanley New York, NY

21.7M
Shares

$72.3 Million
0.01% of portfolio
Whitefort Capital Management, LP New York, NY

12.9M
Shares

$42.9 Million
26.34% of portfolio
Black Rock Inc. New York, NY

11.6M
Shares

$38.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.92M
Shares

$29.7 Million
0.0% of portfolio
Two Seas Capital LP Rye, NY

8.39M
Shares

$27.9 Million
10.86% of portfolio

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $499M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account